Request listing updated daily
All Requests
The YODA Project posts proposals once data access has been granted or denied.
335 Results
YODA PROJECT Protocol Number2021-4846
Product(s) of Interest
ERLEADA® (Apalutamide)
No. Trials Provided1
Published
Principal InvestigatorSusan Halabi
Duke University
Reports & Publications
YODA PROJECT Protocol Number2021-4822
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
Ongoing
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2021-4779
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided6
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2021-4778
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2021-4757
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided2
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2021-4684
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2021-4637
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided3
Published
Principal InvestigatorFlorian Naudet
University of Rennes 1
Reports & Publications
YODA PROJECT Protocol Number2021-4602
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided4
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2021-4599
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided6
Published
Principal InvestigatorJiasheng Wang
MetroHealth Medical Center
Reports & Publications
YODA PROJECT Protocol Number2020-4517
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided13
Published
Principal InvestigatorStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München
Reports & Publications
YODA PROJECT Protocol Number2020-4457
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided2
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2020-4417
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided13
Published
Principal InvestigatorFlorian Naudet
Université de Rennes 1
Reports & Publications
YODA PROJECT Protocol Number2020-4409
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Published
Principal InvestigatorFahim Ebrahimi
Clarunis - University Center for Gastrointestinal and Liver Diseases
Reports & Publications
YODA PROJECT Protocol Number2020-4363
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2020-4362
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided4
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2020-4299
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided3
Published
Principal InvestigatorJiasheng Wang
MetroHealth Medical Center
Reports & Publications
YODA PROJECT Protocol Number2020-4244
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Published
Principal InvestigatorRuth Sim
Monash University Malaysia
Reports & Publications
YODA PROJECT Protocol Number2020-4215
Product(s) of Interest
TRACLEER® (Bosentan), OPSUMIT® (Macitentan)
No. Trials Provided3
Published
Principal InvestigatorFasihul Khan
University of Nottingham
Reports & Publications
YODA PROJECT Protocol Number2020-4211
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Published
Principal InvestigatorLinong Ji
Peking University People's Hospital
Reports & Publications
YODA PROJECT Protocol Number2020-4175
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided7
Published
Principal InvestigatorGeorgios Schoretsanitis
Zucker Hillside Hospital
Reports & Publications
YODA PROJECT Protocol Number2019-4107
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided8
Published
Principal InvestigatorShomron Ben-Horin
First Affiliated Hospital of Sun Yat-Sen University
Reports & Publications
YODA PROJECT Protocol Number2019-4104
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
McMaster University
Reports & Publications
YODA PROJECT Protocol Number2019-4105
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
McMaster University
Reports & Publications
YODA PROJECT Protocol Number2019-4093
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Published
Principal InvestigatorBasem Mishriky
East Carolina University
Reports & Publications
YODA PROJECT Protocol Number2019-4080
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided23
Published
Principal InvestigatorAndrew Jaffe
BlackThorn Therapeutics
Reports & Publications
YODA PROJECT Protocol Number2019-4078
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided3
Published
Principal InvestigatorJonathan Rabinowitz
Bar Ilan University
Reports & Publications
YODA PROJECT Protocol Number2019-4026
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2019-3990
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Published
Principal InvestigatorKlara Kvorning Ternov
Herlev and Gentofte Hospital
Reports & Publications
YODA PROJECT Protocol Number2019-3980
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorNeeraj Narula
McMaster University
Reports & Publications
YODA PROJECT Protocol Number2019-3978
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided39
Published
Principal InvestigatorAlexander Hodkinson
University of Manchester
Reports & Publications
YODA PROJECT Protocol Number2019-3943
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorAdam Cheifetz
Beth Israel Deaconess Medical Center
Reports & Publications
YODA PROJECT Protocol Number2019-3941
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided23
Ongoing
Principal InvestigatorSøren Dinesen Østergaard
Aarhus University
Reports & Publications
YODA PROJECT Protocol Number2019-3893
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
Published
Principal InvestigatorMichael Ward
NIH
Reports & Publications
YODA PROJECT Protocol Number2019-3821
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA®
No. Trials Provided18
Published
Principal InvestigatorRobert McCutcheon
King's College London
Reports & Publications
YODA PROJECT Protocol Number2018-3813
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Published
Principal InvestigatorRebeca Lozano
Spanish National Cancer Research Centre (CNIO)
Reports & Publications
YODA PROJECT Protocol Number2018-3737
Product(s) of Interest
STELARA® (Ustekinumab), SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided23
Published
Principal InvestigatorShailja Shah
Vanderbilt University Medical Center
Reports & Publications
YODA PROJECT Protocol Number2018-3704
Product(s) of Interest
SIMPONI® (Golimumab), PLIVENSIA (Sirukumab)
No. Trials Provided2
Published
Principal InvestigatorDaniel Aletaha
Medical University Vienna
Reports & Publications
YODA PROJECT Protocol Number2018-3236
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorAnnemarie de Vries
Erasmus University Medical Center
Reports & Publications
YODA PROJECT Protocol Number2018-3121
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
Published
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2018-2761
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorMary Lucy Marques
Leiden University Medical Center, The Netherlands
Reports & Publications
YODA PROJECT Protocol Number2018-2686
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Published
Principal InvestigatorBenjamin Kearns
The University of Sheffield
Reports & Publications
YODA PROJECT Protocol Number2017-2326
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Published
Principal InvestigatorLiana Fraenkel
Yale University School of Medicine
Reports & Publications
YODA PROJECT Protocol Number2017-2306
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided5
Published
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2031
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2017-1966
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided19
Published
Principal InvestigatorJose M Rubio
The Zucker Hillside Hospital, Northwell Health
Reports & Publications
YODA PROJECT Protocol Number2017-1856
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided17
Published
Principal InvestigatorAshwin Ananthakrishnan
Massachusetts General Hospital
Reports & Publications
YODA PROJECT Protocol Number2017-1846
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided62
Published
Principal InvestigatorAndreas Heinz
Department of Psychiatry und Psychotherapy, Charité-Universitätsmedizin Berlin
Reports & Publications
YODA PROJECT Protocol Number2017-1746
Product(s) of Interest
TOPAMAX® (Topiramate), SIMPONI® (Golimumab), INVOKANA® (Canagliflozin), REMICADE® (Infliximab), STELARA® (Ustekinumab), RAZADYNE® (Galantamine), RISPERDAL® (Risperidone)
No. Trials Provided43
Published
Principal InvestigatorDavid McAllister
University of Glasgow
Reports & Publications
YODA PROJECT Protocol Number2017-1706
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
Published
Principal InvestigatorZenas Yiu
University of Manchester, UK
Reports & Publications
YODA PROJECT Protocol Number2017-1701
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided6
Published
Principal InvestigatorHiroyuki Uchida
Keio University School of Medicine, Department of Neuropsychiatry
Reports & Publications
YODA PROJECT Protocol Number2017-1676
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone)
No. Trials Provided11
Published
Principal InvestigatorHiroyuki Uchida
Keio University School of Medicine, Department of Neuropsychiatry
Reports & Publications
YODA PROJECT Protocol Number2017-1671
Product(s) of Interest
RAZADYNE® (Galantamine), RAZADYNE® (Galantamine hydrobromide)
No. Trials Provided5
Published
Principal InvestigatorAndrea Tricco
Li Ka Shing Knowledge Institute, St. Michael's Hospital
Reports & Publications
YODA PROJECT Protocol Number2017-1451
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
Published
Principal InvestigatorJosé da Silva
Centro Hospitalar e Universitário de Coimbra
Reports & Publications
YODA PROJECT Protocol Number2017-1356
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Published
Principal InvestigatorYao Zhu
Fudan University
Reports & Publications
YODA PROJECT Protocol Number2017-1276
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorAdam Cheifetz
Beth Israel Deaconess Medical Center
Reports & Publications
YODA PROJECT Protocol Number2016-1176
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorPeter Higgins
University of Michigan
Reports & Publications
YODA PROJECT Protocol Number2016-1122
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Published
Principal InvestigatorAntonio Finelli
Princess Margaret Cancer Centre
Reports & Publications
YODA PROJECT Protocol Number2016-1103
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Published
Principal InvestigatorPaul Toren
Université Laval
Reports & Publications
YODA PROJECT Protocol Number2016-1057
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Published
Principal InvestigatorBenjamin Teply
University of Nebraska Medical Center
Reports & Publications
YODA PROJECT Protocol Number2016-0912
Product(s) of Interest
THERMOCOOL® SMARTTOUCH™ Catheter (Ablation Catheter)
No. Trials Provided1
Published
Principal InvestigatorMark Huffman
Northwestern University, Feinberg School of Medicine
Reports & Publications
YODA PROJECT Protocol Number2016-0903
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
Published
Principal InvestigatorJean Frédéric Colombel
Mount Sinai Medical Center
Reports & Publications
YODA PROJECT Protocol Number2016-0897
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
Published
Principal InvestigatorMark Corbett
University of York
Reports & Publications
YODA PROJECT Protocol Number2016-0880
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided49
Published
Principal InvestigatorStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München
Reports & Publications
YODA PROJECT Protocol Number2016-0734
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
Published
Principal InvestigatorLawrence Mbuagbaw
McMaster University
Reports & Publications
YODA PROJECT Protocol Number2016-0716
Product(s) of Interest
INVEGA®
No. Trials Provided1
Published
Principal InvestigatorLinda Valeri
Columbia University
Reports & Publications
YODA PROJECT Protocol Number2015-0678
Product(s) of Interest
INVEGA®
No. Trials Provided1
Published
Principal InvestigatorSharon-Lise Normand
Harvard Medical School
Reports & Publications
YODA PROJECT Protocol Number2015-0617
Product(s) of Interest
INVEGA®
No. Trials Provided1
Concluded
Principal InvestigatorKarestan Koenen
Harvard School of Public Health
Reports & Publications
YODA PROJECT Protocol Number2015-0612
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided16
Published
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2015-0514
Product(s) of Interest
LEVAQUIN® (Levofloxacin)
No. Trials Provided1
Published
Principal InvestigatorGeoffrey Mospan
Wingate University School of Pharmacy
Reports & Publications
YODA PROJECT Protocol Number2014-0401
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorPeter Higgins
University of Michigan
Reports & Publications
YODA PROJECT Protocol Number2014-0340
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
Published
Principal InvestigatorHeidi Storgaard
Center for Diabetes Research
Reports & Publications
YODA PROJECT Protocol Number2014-0334
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
Published
Principal InvestigatorRaymond Cross
University of Maryland, Baltimore
Reports & Publications
YODA PROJECT Protocol Number2014-0291
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided3
Published
Principal InvestigatorMichael Ward
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Reports & Publications
YODA PROJECT Protocol Number2021-4683
Product(s) of Interest
RAZADYNE® (Galantamine), TOPAMAX® (Topiramate), RISPERDAL® (Risperidone)
No. Trials Provided11
Concluded
Principal InvestigatorChaim Singal
experimind ltd ( Data Science and Sattsistics )
Reports & Publications
YODA PROJECT Protocol Number2020-4474
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Concluded
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2020-4444
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided9
Concluded
Principal InvestigatorJulie Suhr
Ohio University
Reports & Publications
YODA PROJECT Protocol Number2020-4189
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided17
Concluded
Principal InvestigatorLorenzo Trippa
Harvard School of Public Health
Reports & Publications
YODA PROJECT Protocol Number2020-4165
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Concluded
Principal InvestigatorZaid Hattab
National University Of Ireland Galway
Reports & Publications
YODA PROJECT Protocol Number2019-4071
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided15
Concluded
Principal InvestigatorFrank Moriarty
Royal College of Surgeons in Ireland
Reports & Publications
YODA PROJECT Protocol Number2019-4015
Product(s) of Interest
PLIVENSIA (Sirukumab)
No. Trials Provided2
Concluded
Principal InvestigatorJohn Peipert
Northwestern University
Reports & Publications
YODA PROJECT Protocol Number2019-3936
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), ZYTIGA® (Abiraterone acetate), RAZADYNE® (Galantamine), DARZALEX® (Daratumumab)
No. Trials Provided6
Concluded
Principal InvestigatorCharles Iaconangelo
Pharmerit, LP
Reports & Publications
YODA PROJECT Protocol Number2019-3829
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
Concluded
Principal InvestigatorLee Van Horn
University of New Mexico
Reports & Publications
YODA PROJECT Protocol Number2018-3765
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided16
Concluded
Principal InvestigatorAhmad Abuhelwa
University of Sharjah
Reports & Publications
YODA PROJECT Protocol Number2018-3745
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Concluded
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
Reports & Publications
YODA PROJECT Protocol Number2018-3126
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided7
Concluded
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2018-3131
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided7
Concluded
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2018-3061
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
Concluded
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2018-3051
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided1
Concluded
Principal InvestigatorNobuhisa Kanahara
Chiba University Center for Forensic Mental Health
Reports & Publications
YODA PROJECT Protocol Number2018-2801
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Concluded
Principal InvestigatorXianming Tan
University North Carolina at Chapel hill
Reports & Publications
YODA PROJECT Protocol Number2017-2651
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Concluded
Principal InvestigatorChristian Fankhauser
University Hospital of Zurich
Reports & Publications
YODA PROJECT Protocol Number2017-2511
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Concluded
Principal InvestigatorRaphaël Porcher
Université Paris Descartes
Reports & Publications
YODA PROJECT Protocol Number2017-1456
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided3
Concluded
Principal InvestigatorLihi Eder
University of Toronto, Women's College Research Institute
Reports & Publications
YODA PROJECT Protocol Number2016-1171
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Concluded
Principal InvestigatorGirish Kulkarni
University of Toronto/Princess Margaret Cancer Centre
Reports & Publications
YODA PROJECT Protocol Number2016-1058
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Concluded
Principal InvestigatorDaniel Moreira
University of Illinois at Chicago
Reports & Publications
YODA PROJECT Protocol Number2016-1046
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Concluded
Principal InvestigatorAdam Cheifetz
Beth Israel Deaconess Medical Center
Reports & Publications
YODA PROJECT Protocol Number2016-1038
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided2
Concluded
Principal InvestigatorAnthony Daniels
UCB Biosciences
Reports & Publications
YODA PROJECT Protocol Number2016-0995
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Concluded
Principal InvestigatorLaura Coates
University of Leeds
Reports & Publications
YODA PROJECT Protocol Number2016-0979
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Concluded
Principal InvestigatorAntonio Finelli
Princess Margaret Cancer Centre
Reports & Publications
YODA PROJECT Protocol Number2016-0960
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided8
Concluded
Principal InvestigatorGary Rosner
Johns Hopkins University
Reports & Publications
YODA PROJECT Protocol Number2016-0884
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
Concluded
Principal InvestigatorJose Miguel Fernandez
Universidad Pompeu Fabra
Reports & Publications
YODA PROJECT Protocol Number2016-0774
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided2
Concluded
Principal InvestigatorCraig French
Monash University
Reports & Publications
YODA PROJECT Protocol Number2016-0767
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
Concluded
Principal InvestigatorDick Menzies
McGill University
Reports & Publications
YODA PROJECT Protocol Number2016-0766
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA® , INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided15
Concluded
Principal InvestigatorJamie Joseph
UC San Diego
Reports & Publications
YODA PROJECT Protocol Number2016-0725
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone)
No. Trials Provided12
Concluded
Principal InvestigatorJayesh Kamath
University of Connecticut Health Center
Reports & Publications
YODA PROJECT Protocol Number2016-0698
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
Concluded
Principal InvestigatorAndreas Goebel
University of Liverpool
Reports & Publications
YODA PROJECT Protocol Number2015-0691
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided21
Concluded
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2015-0677
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided8
Concluded
Principal Investigatorshomron Ben-Horin
Sheba Medical Center & Sun YatSen 1st affiliated hospital
Reports & Publications
YODA PROJECT Protocol Number2015-0676
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone), RISPERDAL® (Risperidone)
No. Trials Provided2
Concluded
Principal InvestigatorRobin Emsley
Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch
Reports & Publications
YODA PROJECT Protocol Number2015-0649
Product(s) of Interest
REMICADE® (Infliximab), TOPAMAX® (Topiramate), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided20
Concluded
Principal InvestigatorChunhua Weng
Columbia University
Reports & Publications
YODA PROJECT Protocol Number2015-0587
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided1
Concluded
Principal InvestigatorGustavo Velásquez
Brigham and Women's Hospital
Reports & Publications
YODA PROJECT Protocol Number2015-0565
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Concluded
Principal InvestigatorSrikala Sridhar
Princess Margaret Cancer Center
Reports & Publications
YODA PROJECT Protocol Number2015-0527
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided9
Concluded
Principal InvestigatorByron Vaughn
University of Minnesota
Reports & Publications
YODA PROJECT Protocol Number2015-0522
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Concluded
Principal InvestigatorByron Vaughn
University of Minnesota
Reports & Publications
YODA PROJECT Protocol Number2015-0416
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
Concluded
Principal InvestigatorKristina Rother
National Institute of Health
Reports & Publications
YODA PROJECT Protocol Number2014-0317
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone)
No. Trials Provided2
Concluded
Principal InvestigatorJohn Carlson
Michigan State University - School Psychology Doctoral Program
Reports & Publications
YODA PROJECT Protocol Number2023-5212
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided22
Submitted for YODA Project Review
Principal InvestigatorRuby Greywoode
Rutgers Robert Wood Johnson
YODA PROJECT Protocol Number2023-5198
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided10
Approved Pending DUA Signature
Principal InvestigatorPaul Trichelair
Owkin
YODA PROJECT Protocol Number2023-5192
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorGaurav Syal
UC San Diego Health
YODA PROJECT Protocol Number2023-5187
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided6
Ongoing
Principal InvestigatorYao Zhu
Fudan University Shanghai Cancer Center
YODA PROJECT Protocol Number2023-5178
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorThomas Ullman
Montefiore Health Sytem
YODA PROJECT Protocol Number2023-5173
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided2
Ongoing
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
YODA PROJECT Protocol Number2023-5162
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided5
Ongoing
Principal InvestigatorJiaqi Song
Department of Health Statistics, Naval Medical University
YODA PROJECT Protocol Number2023-5158
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Ongoing
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
YODA PROJECT Protocol Number2023-5149
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided12
Ongoing
Principal InvestigatorMysa Myers
Carleton University
YODA PROJECT Protocol Number2023-5145
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided4
Ongoing
Principal InvestigatorJames Wason
Newcastle University
YODA PROJECT Protocol Number2023-5137
Product(s) of Interest
ERLEADA® (Apalutamide)
No. Trials Provided1
Ongoing
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
YODA PROJECT Protocol Number2023-5129
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided2
Approved Pending DUA Signature
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
YODA PROJECT Protocol Number2022-5123
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided8
Ongoing
Principal InvestigatorMichael Andersen
Department of Clinical pharmacology
YODA PROJECT Protocol Number2022-5120
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided10
Ongoing
Principal InvestigatorBobby Lo
Gastrounit, medical section, Copenhagen University Hospital Hvidovre
YODA PROJECT Protocol Number2022-5108
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided1
Ongoing
Principal InvestigatorFredrik Schjesvold
Oslo University Hospital
YODA PROJECT Protocol Number2022-5106
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided9
Ongoing
Principal InvestigatorDaniele Robesti
IRCCS Ospedale San Raffaele, URI
YODA PROJECT Protocol Number2022-5105
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided3
Approved Pending DUA Signature
Principal InvestigatorKathy Liu
Division of Psychiatry, University College London
YODA PROJECT Protocol Number2022-5104
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided6
Ongoing
Principal InvestigatorRirong Chen
The first affiliated hospital of Sun Yet-sen University
YODA PROJECT Protocol Number2022-5102
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided11
Ongoing
Principal InvestigatorGlen Hazlewood
University of Calgary
YODA PROJECT Protocol Number2022-5100
Product(s) of Interest
Vitesse Intracranial Stent (N/A)
No. Trials Provided1
Ongoing
Principal InvestigatorAdnan Qureshi
University of Missouri
YODA PROJECT Protocol Number2022-5091
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided3
Ongoing
Principal InvestigatorJonathan Rabinowitz
Bar Ilan University
YODA PROJECT Protocol Number2022-5090
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), TOPAMAX® (Topiramate)
No. Trials Provided17
Ongoing
Principal InvestigatorJonathan Rabinowitz
Bar Ilan University
YODA PROJECT Protocol Number2022-5088
Product(s) of Interest
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorWenrui Hao
Penn State University
YODA PROJECT Protocol Number2022-5080
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided3
Ongoing
Principal InvestigatorDafne Capelusnik
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands
YODA PROJECT Protocol Number2022-5076
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided5
Ongoing
Principal InvestigatorWeihao Wang
Beijing Hospital
YODA PROJECT Protocol Number2022-5067
Product(s) of Interest
UPTRAVI® (Selexipag)
No. Trials Provided1
Ongoing
Principal InvestigatorChetan Naik
Baylor University Medical Center
YODA PROJECT Protocol Number2022-5066
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided7
Ongoing
Principal InvestigatorAhmad Abuhelwa
University of Sharjah
YODA PROJECT Protocol Number2022-5062
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone), INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), TOPAMAX® (Topiramate), RISPERDAL® (Risperidone)
No. Trials Provided30
Ongoing
Principal InvestigatorIssa Dahabreh
Harvard University
YODA PROJECT Protocol Number2022-5060
Product(s) of Interest
STELARA® (Ustekinumab), SIMPONI® (Golimumab), REMICADE® (Infliximab), PLIVENSIA (Sirukumab)
No. Trials Provided19
Ongoing
Principal InvestigatorVijesh Bhute
Imperial College London
YODA PROJECT Protocol Number2022-5058
Product(s) of Interest
ERLEADA® (Apalutamide)
No. Trials Provided1
Ongoing
Principal InvestigatorYao Zhu
Fudan University Shanghai Cancer Center
YODA PROJECT Protocol Number2022-5056
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Ongoing
Principal InvestigatorCelina Gehringer
Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchrester
YODA PROJECT Protocol Number2022-5054
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided16
Ongoing
Principal InvestigatorHer-Shyong Shiah
Taipei Tzu Chi Hospital
YODA PROJECT Protocol Number2022-5053
Product(s) of Interest
RAZADYNE® (Galantamine),
No. Trials Provided10
Approved Pending DUA Signature
Principal InvestigatorKenichiro Sato
University of Tokyo
YODA PROJECT Protocol Number2022-5048
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided5
Ongoing
Principal InvestigatorAhmad Abuhelwa
University of Sharjah
YODA PROJECT Protocol Number2022-5045
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided11
Approved Pending DUA Signature
Principal InvestigatorAdrian Billeter
Visceral Surgery Department, University of Heidelberg
YODA PROJECT Protocol Number2022-5039
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorAdrian Vickers
RTI Health Solutions
YODA PROJECT Protocol Number2022-5037
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided4
Ongoing
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
YODA PROJECT Protocol Number2022-5036
Product(s) of Interest
No. Trials Provided2
Ongoing
Principal InvestigatorJoon-Kyung Seong
Korea University
YODA PROJECT Protocol Number2022-5030
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided4
Ongoing
Principal InvestigatorYao Zhu
Fudan University Shanghai Cancer Center
YODA PROJECT Protocol Number2022-5027
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided4
Ongoing
Principal InvestigatorNeeraj Agarwal
Huntsman Cancer Institute, University of Utah
YODA PROJECT Protocol Number2022-5021
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided5
Ongoing
Principal InvestigatorVipul Jairath
Alimentiv
YODA PROJECT Protocol Number2022-5020
Product(s) of Interest
TREMFYA® (Guselkumab)
No. Trials Provided4
Approved Pending DUA Signature
Principal InvestigatorJunko Takeshita
University of Pennsylvania
YODA PROJECT Protocol Number2022-5013
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided19
Approved Pending DUA Signature
Principal InvestigatorLUCIANA SOUZA
University of Sao Paulo (USP) - School of Arts, Sciences and Humanities (EACH)
YODA PROJECT Protocol Number2022-5012
Product(s) of Interest
STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided8
Ongoing
Principal InvestigatorRirong Chen
The first affiliated hospital of Sun Yet-sen University
YODA PROJECT Protocol Number2022-5011
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
Reports & Publications
Request originally approved but subsequently withdrawn; new analyses added to previously approved request
YODA PROJECT Protocol Number2022-5008
Product(s) of Interest
ERLEADA® (Apalutamide)
No. Trials Provided1
Ongoing
Principal InvestigatorLysbeth (Libby) Floden
Clinical Outcomes Solutions
YODA PROJECT Protocol Number2022-4996
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
Ongoing
Principal InvestigatorLinong Ji
Peking University People's Hospital
YODA PROJECT Protocol Number2022-4992
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided104
Ongoing
Principal InvestigatorStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München
YODA PROJECT Protocol Number2022-4981
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided6
Ongoing
Principal InvestigatorVipul Jairath
The University of Western Ontario
YODA PROJECT Protocol Number2022-4975
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided8
Approved Pending DUA Signature
Principal InvestigatorVipul Jairath
The University of Western Ontario
YODA PROJECT Protocol Number2022-4974
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride), ZYTIGA® (Abiraterone acetate), DARZALEX® (Daratumumab), YONDELIS® (Trabectedin), ERLEADA® (Apalutamide), IMBRUVICA® (Ibrutinib)
No. Trials Provided17
Ongoing
Principal InvestigatorAmanda Hird
Sunnybrook Health Sciences Centre, University of Toronto
YODA PROJECT Protocol Number2022-4962
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
Ongoing
Principal InvestigatorSofia Ramiro
Consultant, Department of Rheumatology, Leiden University Medical Center
YODA PROJECT Protocol Number2022-4961
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Ongoing
Principal InvestigatorCarl Turesson
Clinical Sciences Malmö, Lund University, Malmö
YODA PROJECT Protocol Number2022-4960
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Ongoing
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
YODA PROJECT Protocol Number2022-4952
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided13
Ongoing
Principal InvestigatorHui Zheng
Chengdu University of Traditional Chinese Medicine
YODA PROJECT Protocol Number2022-4951
Product(s) of Interest
PROCRIT® (Epoetin alfa), SIMPONI® (Golimumab), OPSUMIT® (Macitentan), ZYTIGA® (Abiraterone acetate), TOPAMAX® (Topiramate)
No. Trials Provided5
Ongoing
Principal InvestigatorAryelly Rodriguez
The University of Edinburgh
YODA PROJECT Protocol Number2022-4949
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided7
Ongoing
Principal InvestigatorDennis Shung
Yale School of Medicine
YODA PROJECT Protocol Number2022-4942
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided2
Ongoing
Principal Investigatoryao zhu
Fudan University Shanghai Cancer Center
YODA PROJECT Protocol Number2022-4928
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided1
Ongoing
Principal InvestigatorJorge Castillo
Dana-Farber Cancer Institute
YODA PROJECT Protocol Number2022-4901
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided2
Ongoing
Principal InvestigatorParis Charilaou
Weill Cornell Medicine
YODA PROJECT Protocol Number2022-4895
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorFRANCE GINCHEREAU
IQVIA
YODA PROJECT Protocol Number2022-4894
Product(s) of Interest
TREMFYA® (Guselkumab), STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided19
Ongoing
Principal InvestigatorEmilie Sbidian
UPEC, research unit EpiDermE
YODA PROJECT Protocol Number2022-4889
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), YONDELIS® (Trabectedin)
No. Trials Provided4
In progress
Principal InvestigatorAshley Hopkins
Flinders University
YODA PROJECT Protocol Number2022-4888
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Ongoing
Principal InvestigatorJoachim Tan
Monash University
YODA PROJECT Protocol Number2022-4882
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided3
Ongoing
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
YODA PROJECT Protocol Number2022-4869
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided2
Ongoing
Principal InvestigatorLewis Carpenter
Sensyne Health plc
YODA PROJECT Protocol Number2022-4868
Product(s) of Interest
ZYTIGA® (Abiraterone acetate), ERLEADA® (Apalutamide)
No. Trials Provided2
Published
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
Reports & Publications
YODA PROJECT Protocol Number2022-4867
Product(s) of Interest
LEVAQUIN® (Levofloxacin)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorDevin Maraj
New York University
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2022-4860
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorChenLiang Song
China Medical University
Reports & Publications
Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2022-4854
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided3
Ongoing
Principal InvestigatorHwanhee Hong
Duke University School of Medicine
YODA PROJECT Protocol Number2021-4851
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided13
Ongoing
Principal InvestigatorFlorian NAUDET
Univ Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d’Investigation Clinique de Rennes)], F- 35000 Rennes, France; Univ Rennes, CHU Rennes, Inserm, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France
YODA PROJECT Protocol Number2021-4850
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
Ongoing
Principal InvestigatorAbhinav Sharma
McGill University
YODA PROJECT Protocol Number2021-4849
Product(s) of Interest
INVOKANA® (Canagliflozin), OPSUMIT® (Macitentan)
No. Trials Provided2
Ongoing
Principal InvestigatorSergei Filiasov
McMaster University
YODA PROJECT Protocol Number2021-4848
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided6
Ongoing
Principal InvestigatorVipul Jairath
Alimentiv
YODA PROJECT Protocol Number2021-4844
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided12
Ongoing
Principal InvestigatorGustavo Medeiros
Johns Hopkins School of Medicine
YODA PROJECT Protocol Number2021-4841
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorAaron Brant
Weill Cornell Medical College
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2021-4836
Product(s) of Interest
RAZADYNE® (Galantamine)
No. Trials Provided13
Ongoing
Principal InvestigatorNadine Bittner
Charité - Universitätsmedizin Berlin
YODA PROJECT Protocol Number2021-4835
Product(s) of Interest
SPRAVATO® (Esketamine), RISPERDAL® (Risperidone), CONCERTA® (Methylphenidate HCl)
No. Trials Provided12
Ongoing
Principal InvestigatorAmit Etkin
Alto Neuroscience
YODA PROJECT Protocol Number2021-4829
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided9
Ongoing
Principal InvestigatorVipul Jairath
Alimentiv
YODA PROJECT Protocol Number2021-4828
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorMichael Wiese
University of South Australia
Reports & Publications
Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2021-4823
Product(s) of Interest
INVEGA® (Paliperidone)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorMark Weiser
Sheba Medical Center
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2021-4821
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorDevin Peipert
Northwestern University Feinberg School of Medicine
YODA PROJECT Protocol Number2021-4819
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal Investigatoryao zhu
Fudan University Shanghai Cancer Center
YODA PROJECT Protocol Number2021-4818
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided3
Published
Principal InvestigatorGeorge Papakostas
Massachusetts General Hospital
Reports & Publications
YODA PROJECT Protocol Number2021-4814
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided10
Approved Pending DUA Signature
Principal InvestigatorMalcolm Price
Institute of Applied Health Research, University of Birmingham
YODA PROJECT Protocol Number2021-4813
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided3
Ongoing
Principal InvestigatorWataru Fukuokaya
The Jikei University School of Medicine
YODA PROJECT Protocol Number2021-4812
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
Ongoing
Principal InvestigatorAnika Bilal
AdventHealth,
YODA PROJECT Protocol Number2021-4777
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorDaniel George
Duke University Hospital
YODA PROJECT Protocol Number2021-4770
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided1
Ongoing
Principal InvestigatorDiana Bayani
National University of Singapore
YODA PROJECT Protocol Number2021-4766
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided3
Ongoing
Principal InvestigatorTomoya Hirota
University of California San Francisco
YODA PROJECT Protocol Number2021-4764
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided15
Ongoing
Principal InvestigatorFrank Moriarty
Royal College of Surgeons in Ireland
YODA PROJECT Protocol Number2021-4758
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided2
Ongoing
Principal InvestigatorDavid Mathai
Johns Hopkins University School of Medicine
YODA PROJECT Protocol Number2021-4754
Product(s) of Interest
RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone)
No. Trials Provided66
Ongoing
Principal InvestigatorRajiv Radhakrishnan
Yale University
YODA PROJECT Protocol Number2021-4743
Product(s) of Interest
RAZADYNE® (Galantamine),
No. Trials Provided9
Withdrawn/Closed
Principal InvestigatorFelix Beacher
Cool Clinical Consortium for AI and Clinical Science
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2021-4741
Product(s) of Interest
ZAVESCA® (Miglustat)
No. Trials Provided1
Ongoing
Principal InvestigatorElizabeth Berry-Kravis
Rush University Medical Center
YODA PROJECT Protocol Number2021-4740
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided7
Ongoing
Principal InvestigatorAaron Brant
Weill Cornell Medical College
YODA PROJECT Protocol Number2021-4715
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided12
Ongoing
Principal InvestigatorGlen Hazlewood
University of Calgary
YODA PROJECT Protocol Number2021-4712
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided5
Ongoing
Principal InvestigatorWesley Kerr
UCLA
YODA PROJECT Protocol Number2021-4705
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), INVEGA® (Paliperidone)
No. Trials Provided51
Ongoing
Principal InvestigatorBrian Miller
Augusta University Department of Psychiatry
YODA PROJECT Protocol Number2021-4703
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorRebecca Price
University of Pittsburgh
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2021-4698
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
Unknown - Revoked
Principal InvestigatorJuan Lasa
Hospital Britanico
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2021-4668
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
Ongoing
Principal InvestigatorFeng Sun
Department of Epidemiology and Health Statistics, School of Public Health, Peking University
YODA PROJECT Protocol Number2021-4667
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone)
No. Trials Provided23
Ongoing
Principal InvestigatorAghaegbulam Uga
Burrell College of Osteopathic Medicine
YODA PROJECT Protocol Number2021-4666
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Ongoing
Principal InvestigatorYoshie Omachie
National Center of Neurology and Psychiatry
YODA PROJECT Protocol Number2021-4663
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided2
Ongoing
Principal InvestigatorDouglas Sborov
University of Utah - Huntsman Cancer Institute
YODA PROJECT Protocol Number2021-4660
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided5
In progress
Principal InvestigatorMark Yan
Hoffmann-La Roche Limited
YODA PROJECT Protocol Number2021-4658
Product(s) of Interest
SPRAVATO® (Esketamine)
No. Trials Provided8
Approved Pending DUA Signature
Principal InvestigatorStevan Nikolin
University of New South Wales
YODA PROJECT Protocol Number2021-4649
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorGerd Rippin
IQVIA
YODA PROJECT Protocol Number2021-4640
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided3
Unknown - Revoked
Principal InvestigatorSusan Bal
The University of Alabama at Birmingham
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2021-4638
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorSmith Giri
UAB
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2021-4620
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided11
Ongoing
Principal InvestigatorRobert McCutcheon
King's College London
Reports & Publications
2022
YODA PROJECT Protocol Number2021-4575
Product(s) of Interest
RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided20
Published
Principal InvestigatorSeth Hopkins
Sunovion
Reports & Publications
YODA PROJECT Protocol Number2021-4571
Product(s) of Interest
OPSUMIT® (Macitentan), TRACLEER® (Bosentan)
No. Trials Provided3
Unknown - Revoked
Principal InvestigatorDinesh Khanna
University of Michigan
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2021-4568
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone)
No. Trials Provided15
Ongoing
Principal InvestigatorJose M Rubio
The Zucker Hillside Hospital, Northwell Health
YODA PROJECT Protocol Number2021-4567
Product(s) of Interest
No. Trials Provided2
Ongoing
Principal InvestigatorWiesje Maria van der Flier
Full professor, department of Neurology and department of Epidemiology and Data Science.
YODA PROJECT Protocol Number2021-4566
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
YODA PROJECT Protocol Number2021-4565
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorShawn Malone
The Ottawa Hospital Research Institute
YODA PROJECT Protocol Number2020-4553
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Ongoing
Principal InvestigatorRohan Khera
Yale School of Medicine
YODA PROJECT Protocol Number2020-4548
Product(s) of Interest
No. Trials Provided2
Ongoing
Principal InvestigatorAndreas Monsch
University of Basel
YODA PROJECT Protocol Number2020-4535
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Ongoing
Principal InvestigatorChristopher Ma
University of Calgary
YODA PROJECT Protocol Number2020-4529
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Ongoing
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
YODA PROJECT Protocol Number2020-4528
Product(s) of Interest
INVEGA® (Paliperidone)
No. Trials Provided2
Ongoing
Principal InvestigatorJoan Busner
Signant Health
YODA PROJECT Protocol Number2020-4521
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), TOPAMAX® (Topiramate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided30
Unknown - Revoked
Principal InvestigatorJon Steingrimsson
Biostatistics
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2020-4519
Product(s) of Interest
YONDELIS® (Trabectedin)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorTobias Polak
Erasmus Medical Center Rotterdam
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2020-4499
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Ongoing
Principal InvestigatorShu-Chen Wei
faculty
YODA PROJECT Protocol Number2020-4488
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Ongoing
Principal InvestigatorYohei Doi
Osaka University Graduate School of Medicine
YODA PROJECT Protocol Number2020-4465
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided7
Ongoing
Principal InvestigatorElaine Ku
UCSF
YODA PROJECT Protocol Number2020-4454
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), SIMPONI® (Golimumab), PLIVENSIA (Sirukumab)
No. Trials Provided6
Ongoing
Principal InvestigatorFlorian Naudet
University of Rennes 1
YODA PROJECT Protocol Number2020-4453
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorJoanna Harton
University of Pennsylvania Department of Biostatistics, Epidemiology, and Informatics
YODA PROJECT Protocol Number2020-4448
Product(s) of Interest
, RISPERDAL® (Risperidone), RAZADYNE® (Galantamine)
No. Trials Provided8
Ongoing
Principal InvestigatorSheng Luo
Duke University
YODA PROJECT Protocol Number2020-4442
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided5
Ongoing
Principal InvestigatorCatrin Tudur Smith
Health Data Science Department, University of Liverpool
YODA PROJECT Protocol Number2020-4423
Product(s) of Interest
PREZISTA® (Darunavir)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorDéborah Hirt
Service de pharmacologie - Hopital Cochin
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2020-4416
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2020-4415
Product(s) of Interest
OPSUMIT® (Macitentan), UPTRAVI® (Selexipag), TRACLEER® (Bosentan)
No. Trials Provided13
Ongoing
Principal InvestigatorSheila McCartan
Exploristics
YODA PROJECT Protocol Number2020-4413
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorAmbarish Pandey
University of Texas Southwestern Medical Center
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2020-4410
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorAhmad Abuhelwa
University of Sharjah
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2020-4397
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided2
Ongoing
Principal InvestigatorMehul Patel
King's College London
YODA PROJECT Protocol Number2020-4390
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone), RAZADYNE® (Galantamine)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorMohamed Aziz Mezlini
Massachusetts General hospital. Harvard medical school
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2020-4386
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided2
Ongoing
Principal InvestigatorLena Friberg
Uppsala University
YODA PROJECT Protocol Number2020-4359
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorDaniele Modonutti
Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA;
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2020-4341
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided25
Ongoing
Principal InvestigatorDaniel Weinberger
Yale School of Public Health
YODA PROJECT Protocol Number2020-4324
Product(s) of Interest
RAZADYNE® (Galantamine)
No. Trials Provided3
Approved with DUA Signature
Principal InvestigatorIris Sommer
University Medical Center Groningen
YODA PROJECT Protocol Number2020-4323
Product(s) of Interest
RAZADYNE® (Galantamine),
No. Trials Provided8
Ongoing
Principal InvestigatorPaul Schulz
University of Texas Health Science Center Houston
YODA PROJECT Protocol Number2020-4319
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorKenichiro Sato
University of Tokyo
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2020-4318
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
Ongoing
Principal InvestigatorVivek Rudrapatna
University of California, San Francisco
YODA PROJECT Protocol Number2020-4317
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorLei Zhang
Bristol Medical School, University of Bristol
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2020-4311
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorPaul Toren
Université Laval
YODA PROJECT Protocol Number2020-4310
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorFrancis Alenghat
University of Chicago
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2020-4305
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided2
Published
Principal InvestigatorSuzanne Reeves
University College London
Reports & Publications
YODA PROJECT Protocol Number2020-4298
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2020-4276
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided38
Ongoing
Principal InvestigatorThomas Riemer
Charité-Universitätsmedizin Berlin, corporate partner of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Campus Charité Mitte, Charité Universitätsmedizin Berlin
YODA PROJECT Protocol Number2020-4275
Product(s) of Interest
RAZADYNE® (Galantamine),
No. Trials Provided3
Unknown - Revoked
Principal InvestigatorDavid Ennist
Origent Data Sciences, Inc
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2020-4243
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided5
Withdrawn/Closed
Principal InvestigatorMami Seki
Shimane University School of Medicine, Department of Medical Informatics
Reports & Publications
*Request originally approved but subsequently withdrawn: the Data Partner has terminated their license for the requested product
YODA PROJECT Protocol Number2020-4236
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorDaniel Caldeira
Universidade de Lisboa
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2020-4234
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Published
Principal InvestigatorNeeraj Narula
Hamilton Health Sciences
Reports & Publications
YODA PROJECT Protocol Number2020-4231
Product(s) of Interest
TRACLEER® (Bosentan)
No. Trials Provided1
Ongoing
Principal InvestigatorFasihul Khan
University of Nottingham
YODA PROJECT Protocol Number2020-4213
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorAmbarish Pandey
University of Texas Southwestern Medical Center
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2019-4146
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorGerhardt Attard
UCL
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2019-4134
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorJayne Tierney
MRC Clinical Trials Unit at UCL
YODA PROJECT Protocol Number2019-4133
Product(s) of Interest
TREMFYA® (Guselkumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorJunko Takeshita
University of Pennsylvania
Reports & Publications
*Request originally approved but subsequently withdrawn: data from other sources not received
YODA PROJECT Protocol Number2019-4132
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorMaureen Dubreuil
Boston University School of Medicine
Reports & Publications
*Request withdrawn prior to approval determination: Data Partner supports access through independent process
YODA PROJECT Protocol Number2019-4092
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided11
Ongoing
Principal InvestigatorTianxi Cai
Department of Biostatistics, Harvard T.H. Chan School of Public Health
YODA PROJECT Protocol Number2019-4090
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Unknown - Revoked
Principal Investigatorantoine THIERY-VUILLEMIN
Department of Medical Oncology, CHU Jean Minjoz, Franche-Comté, France
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2019-4077
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
Published
Principal InvestigatorMikhail Zaslavskiy
Owkin
Reports & Publications
YODA PROJECT Protocol Number2019-4075
Product(s) of Interest
TRACLEER® (Bosentan), OPSUMIT® (Macitentan), UPTRAVI® (Selexipag)
No. Trials Provided11
Ongoing
Principal InvestigatorShili Lin
The Ohio State University
YODA PROJECT Protocol Number2019-4067
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab), TREMFYA® (Guselkumab)
No. Trials Provided45
Ongoing
Principal InvestigatorFlorence Bourgeois
Harvard Medical School
YODA PROJECT Protocol Number2019-4066
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorPhilip Robinson
University of Queensland
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2019-4035
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorMatthieu Roustit
CHU de Grenoble Alpes
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2019-4023
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorBenjamin Gandesbery
Barnes-Jewish Hospital
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2019-4013
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorMiguel Rodrigo-Aliaga
Hospital General Universitario Castellon
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2019-4001
Product(s) of Interest
HEALOS® (HEALOS and Leopard Cage)
No. Trials Provided1
Not Approved
Principal InvestigatorLouie Fielding
Empirical Spine, Inc.
YODA PROJECT Protocol Number2019-3999
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided16
Ongoing
Principal InvestigatorThomas G. Riemer
Charité Universitaetsmedizin Berlin
YODA PROJECT Protocol Number2019-3995
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided12
Ongoing
Principal InvestigatorJiaoyang Zheng
ChangZheng Hospital
YODA PROJECT Protocol Number2019-3958
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), TOPAMAX® (Topiramate), SPRAVATO® (Esketamine), RISPERDAL CONSTA® (Risperidone), INVEGA® (Paliperidone), CONCERTA® (Methylphenidate HCl), RISPERDAL® (Risperidone)
No. Trials Provided122
Ongoing
Principal InvestigatorBo Cao
University of Alberta
YODA PROJECT Protocol Number2019-3938
Product(s) of Interest
RISPERDAL® (Risperidone), CONCERTA® (Methylphenidate HCl)
No. Trials Provided2
Ongoing
Principal InvestigatorGustavo Turecki
Douglas Mental Health University Institute
YODA PROJECT Protocol Number2019-3886
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Published
Principal InvestigatorLin Wang
Johns Hopkins School of Public Health
Reports & Publications
YODA PROJECT Protocol Number2019-3865
Product(s) of Interest
STELARA® (Ustekinumab), TREMFYA® (Guselkumab)
No. Trials Provided6
Unknown - Revoked
Principal InvestigatorRobert Gniadecki
University of Alberta, Department of Medicine & Dentistry, Division of Dermatology
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2019-3864
Product(s) of Interest
PREZISTA® (Darunavir), EDURANT® (Rilpivirine), PROCRIT® (Epoetin alfa)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorKin Wah Fung
National Library of Medicine
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2019-3850
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Ongoing
Principal InvestigatorYang LI
School of Statistics, Renmin University Of China
YODA PROJECT Protocol Number2019-3842
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorAdam Cheifetz
Beth Israel Deaconess Medical Center
Reports & Publications
*Request originally approved but subsequently withdrawn: anticipated insufficient values
YODA PROJECT Protocol Number2019-3840
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorMaya Koren-Michowitz
Shamir (Assaf Harofe Medical Center)
Reports & Publications
*Request withdrawn prior to approval determination: ECG scans not available due to patient privacy concerns
YODA PROJECT Protocol Number2019-3827
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), INVEGA® (Paliperidone), INVEGA®
No. Trials Provided67
Published
Principal InvestigatorAndreas Heinz
Charité - Universitätsmedizin Berlin
Reports & Publications
YODA PROJECT Protocol Number2018-3743
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided6
Ongoing
Principal InvestigatorMirjana Stanic Benic
UHC Rijeka
YODA PROJECT Protocol Number2018-3556
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided22
Ongoing
Principal InvestigatorRuby Greywoode
Rutgers Robert Wood Johnson
YODA PROJECT Protocol Number2018-3476
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided10
Ongoing
Principal InvestigatorVivek Rudrapatna
University of California, San Francisco
YODA PROJECT Protocol Number2018-3321
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided5
Ongoing
Principal InvestigatorPascal Chanu
Genentech
YODA PROJECT Protocol Number2018-3156
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
Ongoing
Principal InvestigatorJasper Stevens
University Medical Center Groningen
YODA PROJECT Protocol Number2018-3011
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2018-2946
Product(s) of Interest
YONDELIS® (Trabectedin)
No. Trials Provided4
Withdrawn/Closed
Principal InvestigatorSujana Movva
Fox Chase Cancer Center
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2018-2931
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided11
Ongoing
Principal InvestigatorSophie Derolez
University Hospital of Tours, France
YODA PROJECT Protocol Number2018-2746
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorKT Park
Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2018-2711
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorIñaki F. Trocóniz
Navarra University
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2017-2486
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided5
Ongoing
Principal InvestigatorElizabeth Wright
NIDDK/NIH
YODA PROJECT Protocol Number2017-2381
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided4
Ongoing
Principal InvestigatorDiane van der Woude
Leiden University Medical Center
YODA PROJECT Protocol Number2017-2036
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Unknown - Revoked
Principal InvestigatorAntonio Fojo
Columbia University Medical Center/ James J. Peters VA Medical Center
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2017-1816
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Ongoing
Principal InvestigatorAngus Jones
University of Exeter
YODA PROJECT Protocol Number2017-1521
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), RISPERDAL® (Risperidone)
No. Trials Provided9
Unknown - Revoked
Principal InvestigatorKeturah Faurot
University of North Carolina at Chapel Hill
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2017-1466
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
Unknown - Revoked
Principal InvestigatorAdam Kapelner
Queens College, CUNY
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2016-1196
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Ongoing
Principal InvestigatorMaya Buch
University of Leeds
YODA PROJECT Protocol Number2016-1136
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Published
Principal InvestigatorGuillermo de Velasco
University Hospital 12 de Octubre
Reports & Publications
YODA PROJECT Protocol Number2016-1107
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided7
Unknown - Revoked
Principal InvestigatorFrank Scott
University of Colorado Anschutz Medical Campus
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-1026
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided8
Withdrawn/Closed
Principal InvestigatorIssa Dahabreh
Brown University
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2016-1005
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided38
Ongoing
Principal InvestigatorAdam Chekroud
Yale University
YODA PROJECT Protocol Number2016-0994
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAlex Sturm
University of California, Los Angeles
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2016-0969
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided4
Unknown - Revoked
Principal InvestigatorSuzanne Reeves
University College London
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-0919
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided12
Unknown - Revoked
Principal InvestigatorPurna C. Kashyap
Mayo Clinic
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-0765
Product(s) of Interest
RAZADYNE® (Galantamine)
No. Trials Provided12
Unknown - Revoked
Principal InvestigatorPhilip Bath
University of Nottingham
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2016-0738
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorChristophe Moreno
CUB Hôpital Erasme
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2015-0644
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), TOPAMAX® (Topiramate)
No. Trials Provided31
Ongoing
Principal InvestigatorHwanhee Hong
Duke University School of Medicine
YODA PROJECT Protocol Number2015-0592
Product(s) of Interest
CONCERTA® (Methylphenidate HCl), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), RAZADYNE® (Galantamine)
No. Trials Provided38
Withdrawn/Closed
Principal InvestigatorYang Yan
Holmusk
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2015-0560
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided3
Unknown - Revoked
Principal InvestigatorAlexis Ogdie
University of Pennsylvania
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2015-0556
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorSigrid Nelson
Robarts Clinical Trials
Reports & Publications
*Request withdrawn prior to approval determination: endoscopy videos not available due to patient privacy concerns
YODA PROJECT Protocol Number2015-0539
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAlex Sturm
University of California, Los Angeles
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested
YODA PROJECT Protocol Number2015-0501
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAnthony Otley
IWK Health Centre
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested
YODA PROJECT Protocol Number2015-0500
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorUrban Emmenegger
Sunnybrook Odette Cancer Centre
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested
YODA PROJECT Protocol Number2015-0406
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorNicola Schieda
The Ottawa Hospital - The University of Ottawa
Reports & Publications
*Request originally approved but subsequently withdrawn: CT scans not available due to patient privacy concerns
YODA PROJECT Protocol Number2014-0364
Product(s) of Interest
INVEGA® (Paliperidone), TOPAMAX® (Topiramate), RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided20
Ongoing
Principal InvestigatorStefan Leucht
Klinik für Psychiatrie und Psychotherapie der TU-München Klinikum rechts der Isar
YODA PROJECT Protocol Number2015-0339
Product(s) of Interest
TREMFYA® (Guselkumab), SIMPONI® (Golimumab), STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided64
Published
Principal InvestigatorAtsushi Sakuraba
University of Chicago
Reports & Publications
YODA PROJECT Protocol Number2014-0333
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorGuru Sonpavde
University of Alabama, Birmingham (UAB) School of Medicine
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2014-0287
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorWilliam J. Sandborn
University of California San Diego
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested